You are here: Industry Insights > COVID-19 Vaccine

News List

EMA begins rolling review of Moderna’s COVID-19 vaccine candidate expresspharma
November 18, 2020
Moderna also announced a supply agreement with the UK government to supply mRNA-1273, if approved for use by MHRA.
Moderna COVID-19 Vaccine Candidate Meets Primary Efficacy Endpoint americanpharmaceuticalreview
November 17, 2020
Moderna announced the independent, NIH-appointed Data Safety Monitoring Board (DSMB) for the Phase 3 study of mRNA-1273, its vaccine candidate against COVID-19, has informed Moderna that the trial has met the statistical criteria pre-specified in the ...
Janssen begins second Phase III Covid-19 vaccine trial pharmaceutical-technology
November 17, 2020
The Janssen Pharmaceutical Companies of Johnson & Johnson (J&J) has initiated enrolment and dosing of participants in the Phase III ENSEMBLE 2 trial of a two-dose regimen of JNJ-78436735, an investigational vaccine candidate for preventing Covid-19 ...
Bharat Biotech commences Phase III trials for COVAXIN expresspharma
November 17, 2020
Phase III trials will involve 26,000 volunteers across India who will receive two intramuscular injections, approximately 28 days apart.
Moderna, Pfizer raise bar for COVID-19 vaccines, may ward off competing candidates: GlobalData expresspharma
November 17, 2020
While the most effective vaccines will ramp up production to meet global demand, the opportunity for less effective vaccines will wane.
Medicago and GSK announce start of Phase 2/3 clinical trials of adjuvanted COVID-19 vaccine candidate worldpharmanews
November 16, 2020
Medicago, a biopharmaceutical company headquartered in Quebec City, and GSK have announced the start of Phase 2/3 clinical trials of its plant-derived vaccine candidate for COVID-19 to evaluate its efficacy, safety, and immunogenicity.
EU secures 300 million doses of BioNTech, Pfizer’s COVID-19 vaccine pharmatimes
November 16, 2020
The European Commission has secured a supply deal with BioNTech and Pfizer for 300 million doses of their COVID-19 vaccine candidate.
NIHR establishes new patient recruitment research centres pharmatimes
November 16, 2020
The National Institute for Health Research (NIHR) has launched five national patient recruitment centres (NPRCs) to accelerate and aid life sciences companies to deliver late-stage clinical research within the NHS.
OSE Provides Update on COVID-19 Vaccine americanpharmaceuticalreview
November 16, 2020
OSE Immunotherapeutics has announced successful completion of its human ex vivo study with CoVepiT, a prophylactic vaccine based on optimized epitopes selected to induce a lasting sentinel T lymphocyte immune response against SARS-CoV-2, the virus that ..
Israel to enter into a deal with Pfizer for COVID-19 vaccine expresspharma
November 16, 2020
The supply would begin in January 2021, with the remainder arriving throughout the course of 2021: Israel’s Health Minister.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page